These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12048146)

  • 1. Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive rate-limiters for the development of social behavior skills.
    Smith TE; Hull JW; Huppert JD; Silverstein SM
    Schizophr Res; 2002 Jun; 55(3):229-37. PubMed ID: 12048146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder.
    Smith TE; Hull JW; Goodman M; Hedayat-Harris A; Willson DF; Israel LM; Munich RL
    J Nerv Ment Dis; 1999 Feb; 187(2):102-8. PubMed ID: 10067950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight and recovery from psychosis in chronic schizophrenia and schizoaffective disorder patients.
    Smith TE; Hull JW; Huppert JD; Silverstein SM; Anthony DT; McClough JF
    J Psychiatr Res; 2004; 38(2):169-76. PubMed ID: 14757331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms and neurocognition as rate limiters in skills training for psychotic patients.
    Smith TE; Hull JW; Romanelli S; Fertuck E; Weiss KA
    Am J Psychiatry; 1999 Nov; 156(11):1817-8. PubMed ID: 10553750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia.
    Granholm E; McQuaid JR; McClure FS; Auslander LA; Perivoliotis D; Pedrelli P; Patterson T; Jeste DV
    Am J Psychiatry; 2005 Mar; 162(3):520-9. PubMed ID: 15741469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report.
    Fisher M; Nahum M; Howard E; Rowlands A; Brandrett B; Kermott A; Woolley J; Vinogradov S
    Psychiatr Rehabil J; 2017 Mar; 40(1):21-32. PubMed ID: 28368179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to cognitive remediation in service recipients with severe mental illness.
    Lindenmayer JP; Ozog VA; Khan A; Ljuri I; Fregenti S; McGurk SR
    Psychiatr Rehabil J; 2017 Mar; 40(1):61-69. PubMed ID: 28368180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition.
    Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of clinically meaningful relationships among cognition, functionality, and symptoms in subjects with schizophrenia or schizoaffective disorder.
    Pandina G; Bilder R; Turkoz I; Alphs L
    Schizophr Res; 2013 Feb; 143(2-3):312-8. PubMed ID: 23276482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder.
    O'Reilly K; Donohoe G; Coyle C; O'Sullivan D; Rowe A; Losty M; McDonagh T; McGuinness L; Ennis Y; Watts E; Brennan L; Owens E; Davoren M; Mullaney R; Abidin Z; Kennedy HG
    BMC Psychiatry; 2015 Jul; 15():155. PubMed ID: 26159728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved cognitive function in schizophrenia after one year of cognitive training and vocational services.
    Greig TC; Zito W; Wexler BE; Fiszdon J; Bell MD
    Schizophr Res; 2007 Nov; 96(1-3):156-61. PubMed ID: 17669629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatology and the prediction of social skills acquisition in schizophrenia.
    Mueser KT; Kosmidis MH; Sayers MD
    Schizophr Res; 1992 Oct; 8(1):59-68. PubMed ID: 1419934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.
    Bowie CR; Leung WW; Reichenberg A; McClure MM; Patterson TL; Heaton RK; Harvey PD
    Biol Psychiatry; 2008 Mar; 63(5):505-11. PubMed ID: 17662256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of the illness management and recovery program for persons with schizophrenia.
    Färdig R; Lewander T; Melin L; Folke F; Fredriksson A
    Psychiatr Serv; 2011 Jun; 62(6):606-12. PubMed ID: 21632728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive predictors of work outcome in recent-onset schizophrenia.
    Nuechterlein KH; Subotnik KL; Green MF; Ventura J; Asarnow RF; Gitlin MJ; Yee CM; Gretchen-Doorly D; Mintz J
    Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S33-40. PubMed ID: 21860045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.